A comprehensive review of the intersection between asthma and depression

Abstract

Objective

To emphasize the necessity for increased research in this field, incorporating depression into the preventative, diagnostic, and therapeutic considerations for asthma. Additionally, we seek to highlight upcoming advancements that can be applied to simultaneously address these comorbidities, ultimately improving the overall well-being and quality of life for individuals coping with these conditions.

Methods

A rigorous search in PubMed using the MeSH terms “asthma” and “depression” was performed, and papers were screened by the authors in view of their eligibility to contribute to the study.

Results

There exists a correlation between these two conditions, with specific biological mechanisms and genetic factors playing a crucial role in their concurrent occurrence. In this review, we present preclinical and clinical research data, shed light on the possible mechanisms contributing to the co-occurrence of symptoms associated with both asthma and depression, and explore the intricate relationship between both conditions.

Conclusion

The evidence presented here supports the existence of a correlation between asthma and depression. By acknowledging these shared biological mechanisms, genetic factors, and epidemiological trends, we can formulate more efficacious strategies for addressing the dual impact of asthma and depression.

Keywords:

• Hospital anxiety and depression scale (HADS) scores
• health related quality of life (HRQoL)
• major depressive disorder (MDD)
• NF-κB
• oxidative stress

Disclosure statement

The authors have declared no conflicts of interest.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.